Invention Grant
- Patent Title: Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
-
Application No.: US17935140Application Date: 2022-09-26
-
Publication No.: US11701403B2Publication Date: 2023-07-18
- Inventor: Aldo Iacono , Oliver Denk , Gerhard Boerner
- Applicant: Breath Therapeutics GmbH
- Applicant Address: DE Munich
- Assignee: Breath Therapeutics GmbH
- Current Assignee: Breath Therapeutics GmbH
- Current Assignee Address: DE Munich
- Agency: Pharma Patents International AG
- Agent Lily Ackerman
- Priority: EP 172067 2018.05.14
- Main IPC: A61K38/13
- IPC: A61K38/13 ; A61P11/00 ; A61K9/00 ; A61K45/06
Abstract:
The present invention relates to a composition comprising cyclosporine A (CsA) for use in the prevention of bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for the treatment of BOS or for the prevention or delay of the progression of BOS in a double lung transplanted patient being diagnosed with BOS, wherein the composition is administered to said patient by inhalation of said composition in aerosolized form comprising a therapeutically effective dose of cyclo-sporine A.
Public/Granted literature
- US20230128855A1 Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS) Public/Granted day:2023-04-27
Information query
IPC分类:
